DE301871C - - Google Patents
Info
- Publication number
- DE301871C DE301871C DENDAT301871D DE301871DA DE301871C DE 301871 C DE301871 C DE 301871C DE NDAT301871 D DENDAT301871 D DE NDAT301871D DE 301871D A DE301871D A DE 301871DA DE 301871 C DE301871 C DE 301871C
- Authority
- DE
- Germany
- Prior art keywords
- silver
- protein
- glycocholate
- compounds
- glycolic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 12
- 108090000623 proteins and genes Chemical class 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108010007979 Glycocholic Acid Proteins 0.000 claims description 7
- RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical class C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 claims description 7
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims description 6
- 229910052709 silver Inorganic materials 0.000 claims description 5
- 239000004332 silver Substances 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 229910001923 silver oxide Inorganic materials 0.000 claims description 3
- 230000015556 catabolic process Effects 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000007857 degradation product Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 230000017854 proteolysis Effects 0.000 claims description 2
- 150000003378 silver Chemical class 0.000 claims description 2
- 101000868789 Drosophila melanogaster Carboxypeptidase D Proteins 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 229940100890 silver compound Drugs 0.000 claims 1
- 150000003379 silver compounds Chemical class 0.000 claims 1
- -1 silver glycocholate compounds Chemical class 0.000 claims 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- 108010082714 Silver Proteins Proteins 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 108010009004 proteose-peptone Proteins 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE301871T |
Publications (1)
Publication Number | Publication Date |
---|---|
DE301871C true DE301871C (enrdf_load_stackoverflow) |
Family
ID=6102548
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT301871D Active DE301871C (enrdf_load_stackoverflow) | |||
DENDAT292517D Active DE292517C (enrdf_load_stackoverflow) |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT292517D Active DE292517C (enrdf_load_stackoverflow) |
Country Status (1)
Country | Link |
---|---|
DE (2) | DE292517C (enrdf_load_stackoverflow) |
-
0
- DE DENDAT301871D patent/DE301871C/de active Active
- DE DENDAT292517D patent/DE292517C/de active Active
Also Published As
Publication number | Publication date |
---|---|
DE292517C (enrdf_load_stackoverflow) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1695160A1 (de) | Verfahren zur Herstellung einer Cytosinverbindung | |
DE301871C (enrdf_load_stackoverflow) | ||
DE926248C (de) | Verfahren zur Herstellung von Abkoemmlingen des Pyridin-4-carbonsaeurehydrazids | |
DE213155C (enrdf_load_stackoverflow) | ||
CH312531A (de) | Verfahren zur Herstellung eines Pyridazons. | |
DE93112C (enrdf_load_stackoverflow) | ||
AT266860B (de) | Verfahren zur Herstellung des neuen N-p-Chlorbenzoyl-5-fluor-cytosins | |
DE2107866B2 (de) | Thiamphenicolderivate, verfahren zu deren herstellung und antibakterielles mittel | |
DE270255C (enrdf_load_stackoverflow) | ||
CH449012A (de) | Verfahren zur Herstellung von Cholinnicotinat und Cholinesternicotinaten | |
DE859312C (de) | Verfahren zur Herstellung von Dicarbonsaeurederivaten der heterocyclischen Reihe | |
DE203717C (enrdf_load_stackoverflow) | ||
DE613402C (de) | Verfahren zur Darstellung von 4-Pyridylpyridiniumdichlorid | |
DE956755C (de) | Verfahren zur Herstellung von Di-(4-oxy-phenyl)-pyridyl-methanen oder ihren O-Acyl- oder O-Alkyl-derivaten | |
AT239233B (de) | Verfahren zur Herstellung neuer Pyrazolo[3, 4-d]pyrimidine | |
AT258473B (de) | Verfahren zur Herstellung eines konzentrierten, wärmebeständigen Lysozympräparates | |
DE1002318B (de) | Verfahren zur Herstellung von bakteriostatisch wirksamen Oxamidsaeureestern | |
DE581830C (de) | Verfahren zur Herstellung substituierter Acetamide | |
DE524638C (de) | Verfahren zur Darstellung von Pyrazolonen | |
DE261875C (enrdf_load_stackoverflow) | ||
DE292590C (enrdf_load_stackoverflow) | ||
DE120375C (enrdf_load_stackoverflow) | ||
DE274047C (enrdf_load_stackoverflow) | ||
DE293693C (enrdf_load_stackoverflow) | ||
AT37386B (de) | Verfahren zur Darstellung löslicher Stärke. |